NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/15/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization530.25 mln
Float118 mln
Earnings Date08/04/2026
EPS
0.20
Marginal
P / E
17.80
Moderately valued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.67
Likely reliable
1-Year Forecast
6.50
Transformational upside
Relative Strength
36
/ 100
Underperforming
Business Description
MiMedx, founded in 2006 and based in Marietta, Georgia, develops and sells medical products made from human placental tissue, including the membrane, umbilical cord, and placental disc. Using its proprietary PURION processing method, the company preserves the tissue's natural biological elements to create grafts used in wound care, burn treatment, and surgery, with applications ranging from lower extremity repair to orthopedic reconstruction. Products are sold across the United States through a direct sales team, independent agents, and distributors, and the company works alongside Vaporox Inc. to expand its wound care reach.
